| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/02/2000 | CN1243506A Novel modifications to 2-amino-4 (4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene and processes for preparing said compound |
| 02/02/2000 | CN1243439A Use of prumipexole in the treating of restless legs syndrome |
| 02/02/2000 | CN1242987A Qilaxitong preparation |
| 02/02/2000 | CN1048986C Heterocyclic compounds and their preparation and use |
| 02/02/2000 | CN1048985C Piperazine derivatives as 5HT1A antagonists |
| 02/01/2000 | US6020492 Deazapurine derivatives; a new class of CRF1 specific ligands |
| 02/01/2000 | US6020477 DNA sequences coding for the human proteins Tx and Ty related to the interleukin-1β converting enzyme |
| 02/01/2000 | US6020370 Bridged cyclic amino acids as pharmaceutical agents |
| 02/01/2000 | US6020366 Butyric acid matrix metalloproteinase inhibitors |
| 02/01/2000 | US6020358 Substituted phenethylsulfones and method of reducing TNFα levels |
| 02/01/2000 | US6020349 Constrained somatostatin agonists and antagonists |
| 02/01/2000 | US6020348 Endothelin receptor antagonists |
| 02/01/2000 | US6020346 Piperidine derivatives having tachykinin antagonist activity |
| 02/01/2000 | US6020345 Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine |
| 02/01/2000 | US6020336 Indole and indazole compounds |
| 02/01/2000 | US6020335 (N-(pyridinylmethyl)-heterocyclic)ylideneamine compounds as nicotinic acetylcholine receptor binding agents |
| 02/01/2000 | US6020326 Method for inhibition of bone growth by anionic polymers |
| 02/01/2000 | US6020314 Methods for treatment of neurological disorders |
| 02/01/2000 | US6020310 Method for assisting in differential diagnosis and treatment of autistic syndromes |
| 02/01/2000 | US6020197 Neuroblasts are dependant upon about 1 to 100 ng/ml of bfgf for long term maintenance. |
| 02/01/2000 | US6020189 Fibroblast growth factor homologous factors (FHFs) and methods of use |
| 02/01/2000 | US6020179 Nucleic acids encoding human tyrosine phosphatases |
| 02/01/2000 | US6020157 Polynucleotides encoding HFGAN72X receptor |
| 02/01/2000 | US6020143 The invention is concerned with the identification, isolation and cloning of genes which are associated with alzheimer's disease. |
| 02/01/2000 | US6020001 Compositions for treating migraine |
| 02/01/2000 | US6019994 Use of levobupivacaine in treating migraine |
| 02/01/2000 | CA2144947C Serotonin receptor agents |
| 01/27/2000 | WO2000004157A2 Cloning and characterisation of novel mammalian peptidases |
| 01/27/2000 | WO2000004150A1 Human presenilin-associated protein |
| 01/27/2000 | WO2000004144A1 Snurpotine i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 01/27/2000 | WO2000004050A2 Neurotrophic growth factor |
| 01/27/2000 | WO2000004020A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 01/27/2000 | WO2000004019A1 5-bicycloindole compounds |
| 01/27/2000 | WO2000004013A1 Antagonists of gonadotropin releasing hormone |
| 01/27/2000 | WO2000004010A1 Bicyclohexane derivatives |
| 01/27/2000 | WO2000003992A1 Quinoline derivatives |
| 01/27/2000 | WO2000003991A1 Quinoline derivatives |
| 01/27/2000 | WO2000003740A2 Use of (s) (-)-amisulpride for the manufacture of a medicament for the treatment of schizophrenia |
| 01/27/2000 | WO2000003717A1 Method of treatment |
| 01/27/2000 | WO2000003716A1 Topical compositions comprising an opioid analgesic and an nmda antagonist |
| 01/27/2000 | WO2000003715A1 Treatment of dyskinesia |
| 01/27/2000 | WO2000003714A1 Medicinal product and method for treatment and prevention of dyskinesia |
| 01/27/2000 | WO2000003708A1 Analgesic use of podophyllotoxin for treating pain conditions in female genital organs |
| 01/27/2000 | WO2000003701A1 Composition for treatment of stress |
| 01/27/2000 | WO2000003698A1 Transdermal patch and topical compositions comprising propylnorapomorphine |
| 01/27/2000 | WO1999063930A3 Novel angiotensin receptor modulators and their uses |
| 01/27/2000 | WO1999061008A3 Compositions and methods for alleviating impaired mental function, memory loss and reducing recovery time in anaesthetized mammals |
| 01/27/2000 | WO1999060987A3 Control of pain with endogenous cannabinoids |
| 01/27/2000 | WO1999058564B1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use |
| 01/27/2000 | WO1999058527A3 Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient |
| 01/27/2000 | WO1999055388A9 Substituted porphyrins |
| 01/27/2000 | WO1999053959A3 Use of viral vectors for treatment of the injured peripheral and central nervous system |
| 01/27/2000 | DE19918588A1 Piperidinverbindung Piperidine |
| 01/27/2000 | DE19828114A1 Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV Prodrugs unstable inhibitors of dipeptidyl peptidase IV |
| 01/27/2000 | CA2343748A1 5-bicycloindole compounds |
| 01/27/2000 | CA2338054A1 Bicyclohexane derivatives |
| 01/27/2000 | CA2337516A1 Transdermal patch and topical compositions comprising propylnorapomorphine |
| 01/27/2000 | CA2337507A1 Composition for treatment of stress |
| 01/27/2000 | CA2337436A1 Use of (s) (-)-amisulpride for the manufacture of a medicament for the treatment of schizophrenia |
| 01/27/2000 | CA2337407A1 Antagonists of gonadotropin releasing hormone |
| 01/27/2000 | CA2337377A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 01/27/2000 | CA2337362A1 Cloning and characterisation of novel mammalian peptidases |
| 01/27/2000 | CA2337229A1 Method of treatment |
| 01/27/2000 | CA2336998A1 Medicinal product and method for treatment and prevention of dyskinesia |
| 01/27/2000 | CA2333910A1 Neurotrophic growth factor |
| 01/27/2000 | CA2333895A1 Snurportin i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 01/27/2000 | CA2333467A1 Human presenilin-associated protein |
| 01/26/2000 | EP0974664A2 Human polypeptides and polynucleotides homolog to mouse testes-specific angiotensins converting enzyme |
| 01/26/2000 | EP0973903A2 Protein for inhibiting apoptosis |
| 01/26/2000 | EP0973819A1 Non-antigenic branched polymer conjugates |
| 01/26/2000 | EP0973804A2 Anti-vegf antibodies |
| 01/26/2000 | EP0973794A1 Netrin receptors |
| 01/26/2000 | EP0973792A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 01/26/2000 | EP0973777A1 Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission |
| 01/26/2000 | EP0973773A1 Pyrimido-isoquinoline compounds with anticonvulsive action |
| 01/26/2000 | EP0973772A1 Compounds |
| 01/26/2000 | EP0973763A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 01/26/2000 | EP0973749A1 4-aminoalkoxy-1h-benzimidazole derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists |
| 01/26/2000 | EP0973748A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
| 01/26/2000 | EP0973743A1 Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds |
| 01/26/2000 | EP0973741A1 S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist |
| 01/26/2000 | EP0973731A1 Hydroxamic acid derivatives |
| 01/26/2000 | EP0973725A2 New 1,7,7-trimethyl-bicyclo 2.2.1]heptane derivatives |
| 01/26/2000 | EP0973522A1 Topical gel composition containing a combination of a nsaid and a xanthine derivative |
| 01/26/2000 | EP0973516A1 Use of halo and/or nitro-substituted flavonoids as anxyolitics |
| 01/26/2000 | EP0973461A1 Method of treatment of migraine |
| 01/26/2000 | EP0973392A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 01/26/2000 | EP0973390A1 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease |
| 01/26/2000 | EP0778834B1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
| 01/26/2000 | EP0722316B1 New emulsion formulation |
| 01/26/2000 | EP0686145B1 New compounds |
| 01/26/2000 | CN1242772A Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine |
| 01/26/2000 | CN1242367A Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole] |
| 01/26/2000 | CN1242366A Diaza-spiro [3,5] nonane derivatives |
| 01/26/2000 | CN1242197A Microencapsulated bovine adrenal medulla chromaffincell medicine used for treating Parkinson's disease |
| 01/26/2000 | CN1048728C 3-substituted 3H,-2,3-benzodiazepine derivatives, their prepn. and use as medicine |
| 01/26/2000 | CN1048727C Process for prepn. of 2-(1-azabicyclo (2,2,2) oct-3-yl)-2,4,5,6-tetrahydro-1H-benz |
| 01/26/2000 | CN1048720C New O-arylmethyl-N-(thio) acylhydroxylamines, prepn. method and pharmaceutical compositions thereof |
| 01/26/2000 | CN1048718C Phenylethyl and phenylpropylamines compounds, prepn. method, pharmaceutical agent and use thereof |
| 01/25/2000 | US6017963 Formulation for intranasal administration |